-
1
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Antithrombotic Trialists' Collaboration
-
Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002; 324: 71-86.
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
2
-
-
0037046196
-
Aspirin resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
-
Eikelboom JW, Hirsh J, Weitz JI et al. Aspirin resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation, 2002; 105: 1650-1655.
-
(2002)
Circulation
, vol.105
, pp. 1650-1655
-
-
Eikelboom, J.W.1
Hirsh, J.2
Weitz, J.I.3
-
3
-
-
38949119325
-
Aspirin "resistance" and risk of cardiovascular morbidity: Systematic review and meta-analysis
-
Krasopoulos G, Brister SJ, Beattie WS et al. Aspirin " resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ, 2008; 336: 195-198.
-
(2008)
BMJ
, vol.336
, pp. 195-198
-
-
Krasopoulos, G.1
Brister, S.J.2
Beattie, W.S.3
-
4
-
-
0035421783
-
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
-
Gum PA, Kottke-Marchant K, Poggio E et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol, 2001; 88: 230-235.
-
(2001)
Am J Cardiol
, vol.88
, pp. 230-235
-
-
Gum, P.A.1
Kottke-Marchant, K.2
Poggio, E.3
-
5
-
-
33846235920
-
Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
-
Hovens MM, Snoep JD, Eikenboom JC et al. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J, 2007; 153: 175-181.
-
(2007)
Am Heart J
, vol.153
, pp. 175-181
-
-
Hovens, M.M.1
Snoep, J.D.2
Eikenboom, J.C.3
-
7
-
-
84889732880
-
Nieprawidłowa odpowiedź na kwas acetylosalicylowy - Definicje i zasady postȩpowania w świetle poznanych czynników ryzyka
-
Postuła M, Kapłon-Cieślicka A, Rosiak M et al. Nieprawidłowa odpowiedź na kwas acetylosalicylowy - definicje i zasady postȩpowania w świetle poznanych czynników ryzyka. Kardiol Pol, 2008; 66: 313-319.
-
(2008)
Kardiol Pol
, vol.66
, pp. 313-319
-
-
Postuła, M.1
Kapłon-Cieślicka, A.2
Rosiak, M.3
-
8
-
-
18144377710
-
Prevalence of aspirin resistance measured by PFA-100®
-
Coma-Canella I, Velasco A, Castano S. Prevalence of aspirin resistance measured by PFA-100®. Int J Cardiol, 2005; 101: 71-76.
-
(2005)
Int J Cardiol
, vol.101
, pp. 71-76
-
-
Coma-Canella, I.1
Velasco, A.2
Castano, S.3
-
9
-
-
0036344893
-
Clinical application of the PFA-100®
-
Favaloro E. Clinical application of the PFA-100®. Curr Opin Hematol, 2002; 9: 407-415.
-
(2002)
Curr Opin Hematol
, vol.9
, pp. 407-415
-
-
Favaloro, E.1
-
10
-
-
0037669056
-
Is platelet aggregation a more important contributor than platelet adhesion to the overall platelet-related primary haemostasis measured by PFA-100®?
-
Watała C, Golański J, Rozalski M et al. Is platelet aggregation a more important contributor than platelet adhesion to the overall platelet-related primary haemostasis measured by PFA-100®? Thromb Res, 2003; 109: 299-306.
-
(2003)
Thromb Res
, vol.109
, pp. 299-306
-
-
Watała, C.1
Golański, J.2
Rozalski, M.3
-
11
-
-
33846932054
-
Clinical relevance of aspirin resistance in patients with stable coronary artery disease: A prospective follow-up study (PROSPECTAR)
-
Pamukcu B, Oflaz H, Onur I et al. Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR). Blood Coagul Fibrinolysis 2007; 18: 187-192.
-
(2007)
Blood Coagul Fibrinolysis
, vol.18
, pp. 187-192
-
-
Pamukcu, B.1
Oflaz, H.2
Onur, I.3
-
12
-
-
27444431936
-
Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels
-
Borna C, Lazarowski E, van Heusden C et al. Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels Thromb J, 2005; 3: 10-19.
-
(2005)
Thromb J
, vol.3
, pp. 10-19
-
-
Borna, C.1
Lazarowski, E.2
Van Heusden, C.3
-
13
-
-
0034054309
-
Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin
-
Kawasaki T, Ozeki Y, Igawa T et al. Increased sensitivity to collagen in individuals resistant to low-dose aspirin. Stroke, 2000; 31: 591-595. (Pubitemid 30131641)
-
(2000)
Stroke
, vol.31
, Issue.3
, pp. 591-595
-
-
Kawasaki, T.1
Ozeki, Y.2
Igawa, T.3
Kambayashi, J.-I.4
-
14
-
-
0037101578
-
Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate
-
Macchi L, Christiaens L, Brabant S et al. Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate. Thromb Res, 2002; 107: 45-49.
-
(2002)
Thromb Res
, vol.107
, pp. 45-49
-
-
Macchi, L.1
Christiaens, L.2
Brabant, S.3
-
15
-
-
33747088257
-
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: A 700-patient study of aspirin resistance
-
Frelinger AL, Furman MI, Linden MD et al. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Circulation, 2006; 113: 2888-2896.
-
(2006)
Circulation
, vol.113
, pp. 2888-2896
-
-
Frelinger, A.L.1
Furman, M.I.2
Linden, M.D.3
-
16
-
-
0031895889
-
Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease
-
Carney RM, Freedland KE, Eisen SA et al. Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease. Behav Med, 1998; 24: 35-39.
-
(1998)
Behav Med
, vol.24
, pp. 35-39
-
-
Carney, R.M.1
Freedland, K.E.2
Eisen, S.A.3
-
17
-
-
0033578986
-
The rate of acetylsalicylic acid non-respondents among patients hospitalised for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis
-
Tarjan J, Salamon A, Jager R et al. The rate of acetylsalicylic acid non-respondents among patients hospitalised for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis. Orv Hetil, 1999; 140: 2339-2343.
-
(1999)
Orv Hetil
, vol.140
, pp. 2339-2343
-
-
Tarjan, J.1
Salamon, A.2
Jager, R.3
-
18
-
-
16844362580
-
Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction
-
Schwartz KA, Schwartz DE, Ghosheh K et al. Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. Am J Cardiol, 2005; 95: 973-975.
-
(2005)
Am J Cardiol
, vol.95
, pp. 973-975
-
-
Schwartz, K.A.1
Schwartz, D.E.2
Ghosheh, K.3
-
19
-
-
10744228434
-
Lack of aspirin effect: Aspirin resistance or resistance to taking aspirin?
-
Cotter G, Shemesh E, Zehavi M et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J, 2004; 147: 293-300.
-
(2004)
Am Heart J
, vol.147
, pp. 293-300
-
-
Cotter, G.1
Shemesh, E.2
Zehavi, M.3
-
20
-
-
24944468330
-
The role of exercise on platelet aggregation in patients with stable coronary artery disease: Exercise induces aspirin resistant platelet activation
-
Pamukcu B, Oflaz H, Acar R et al. The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation. J Thromb Thrombolysis, 2005a; 20: 17-22.
-
(2005)
J Thromb Thrombolysis
, vol.20
, pp. 17-22
-
-
Pamukcu, B.1
Oflaz, H.2
Acar, R.3
-
21
-
-
0036878918
-
Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease
-
Christiaens L, Macchi L, Herpin D et al. Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease. Thromb Res, 2002; 108: 115-119.
-
(2002)
Thromb Res
, vol.108
, pp. 115-119
-
-
Christiaens, L.1
Macchi, L.2
Herpin, D.3
-
22
-
-
17444366978
-
Platelet reactivity in response to mental stress in syndrome X and in stable or unstable coronary artery disease
-
Sestito A, Maccallini A, Sgueglia GA et al. Platelet reactivity in response to mental stress in syndrome X and in stable or unstable coronary artery disease. Thrombosis Res, 2005: 116: 25-31.
-
(2005)
Thrombosis Res
, vol.116
, pp. 25-31
-
-
Sestito, A.1
Maccallini, A.2
Sgueglia, G.A.3
-
23
-
-
0028288681
-
Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin
-
Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation, 1994; 89: 1951-1957. (Pubitemid 24142768)
-
(1994)
Circulation
, vol.89
, Issue.5
, pp. 1951-1957
-
-
Larsson, P.T.1
Wallen, N.H.2
Hjemdahl, P.3
-
24
-
-
0031013712
-
Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin
-
Santos MT, Valles J, Aznar J et al. Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin. Circulation, 1997; 95: 63-68.
-
(1997)
Circulation
, vol.95
, pp. 63-68
-
-
Santos, M.T.1
Valles, J.2
Aznar, J.3
-
25
-
-
0345131724
-
Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: The effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity
-
Valles J, Santos MT, Aznar J et al. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity. Circulation, 1998; 97: 350-355
-
(1998)
Circulation
, vol.97
, pp. 350-355
-
-
Valles, J.1
Santos, M.T.2
Aznar, J.3
|